Hysteroscopic sterilization leaves patients satisfied

Article

Essure (Conceptus, Inc.), the outpatient, hysteroscopic sterilization procedure that requires no sedation or general anesthesia, received high marks for patient satisfaction in a prospective cohort study.

Essure (Conceptus, Inc.), the outpatient, hysteroscopic sterilization procedure that requires no sedation or general anesthesia, received high marks for patient satisfaction in a prospective cohort study.

Researchers from the United Kingdom reviewed data on 112 women undergoing the procedure. Successful bilateral tubal placement occurred in 92% (95% CI, 85%–96%). No major procedure-related complications were noted, but transient vasovagal reactions occurred in 5% of the women. Bilateral tubal occlusion was confirmed via hysterosalpingogram (HSG) 3 months after the procedure in 83 of the 84 women undergoing HSG (99%; 95% CI, 94%–100%) and in 100% of the women at 6 months after the procedure.

Ninety-six percent (95% CI, 88%–99%) of the women returning questionnaires were satisfied with their overall experience, with 88% reporting being "very satisfied" (95% CI, 78%–94%). The authors of the study commented that scheduling the procedure during the proliferative phase of the menstrual cycle helps to optimize success, especially in the presence of a clinically enlarged uterus.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Ciera Kirkpatrick, PhD, shows how TikTok is transforming cervical cancer awareness | Image Credit: linkedin.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.